_id
6919eec53c536f8df23184f4
Ticker
SUN.LSE
Name
Surgical Innovations Group plc
Exchange
LSE
Address
Clayton Wood House, Leeds, United Kingdom, LS16 6QZ
Country
UK
Sector
Healthcare
Industry
Medical Devices
Currency
GBX
Website
https://www.sigroupplc.com
Description
Surgical Innovations Group plc, together with its subsidiaries, engages in the design, manufacture, and export of medical products for use in laparoscopic and robotic minimally invasive surgery in the United Kingdom, Europe, the Asia Pacific, the United States, and internationally. The company operates through three segments: SI Brand, Original Equipment Manufacturer (OEM), and Distribution. It offers YelloPort Elite port access systems; YelloPort + Resposable port access systems; LogiCut, a disposable laparoscopic scissors; Logic, a reusable laparoscopic grasping forceps and dissectors; LogiFlex, a dual purpose, Resposable device for blunt dissection and gastric band retrieval; FastClamp, a reusable laparoscopic clamping system, designed to fixate a range of instrumentation in position during minimally invasive surgery; PretzelFlex, a pretzel shaped organ and tissue retractor, designed for use in minimally invasive surgery; and LogiTube, a calibration tubing for gastric pouch sizing during sleeve gastrectomy, mini gastric bypass/one-anastomosis gastric bypass, or revision surgery for these procedures. The company also researches, develops, manufactures, and distributes minimally invasive devices for third party medical device companies through either own label or co-branding; minimally invasive technology products for precision engineering applications; and services for design and building of instruments. In addition, it distributes specialist medical products; and designs and manufactures autologous blood products. The company sells its products through independent healthcare distributors, as well as its own label products through OEM relationships. The company was incorporated in 1988 and is headquartered in Leeds, the United Kingdom.
Last Close
4500
Volume
4533270
Current Price
0.402
Change
0
Last Updated
2025-12-30T11:35:35.515Z
Image
https://logo.clearbit.com/www.sigroupplc.com
Ipo Date
-
Market Cap
4197672
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Rating
4
Strong Buy
0
Buy
1
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-06-30
Revenue
6145000
Cost Of Revenue
4224000
Gross Profit
1921000
Operating Expenses
1860000
Operating Income
61000
Interest Expense
40000
Pretax Income
21000
Net Income
21000
Eps
0.000022483097528465208
Dividends Per Share
-
Shares Outstanding
932816177
Income Tax Expense
-
EBITDA
373000
Operating Margin
0.9926769731489016
Total Other Income Expense Net
-40000
Cash
-461000
Short Term Investments
-
Receivables
2602000
Inventories
2600000
Total Current Assets
4741000
Property Plant Equipment
1287000
Total Assets
11500000
Payables
1151000
Short Term Debt
473000
Long Term Debt
-
Total Liabilities
2938000
Equity
8562000
Bs_currency_symbol
-
Depreciation
312000
Change In Working Capital
-515000
Cash From Operations
-239000
Capital Expenditures
25000
Cash From Investing
-120000
Cash From Financing
-310000
Net Change In Cash
-656000
Cf_currency_symbol
-
PE
-
PB
43.85448142957254
ROE
0.2452697967764541
ROA
0.1826086956521739
FCF
-264000
Fcf Percent
-0.042961757526444266
Piotroski FScore
2
Health Score
42
Deep Value Investing Score
6
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
4.8
Garp Investing Score
3
Growth Investing Score
1.5
Momentum Investing Score
3
Net Net Investing Score
2.5
Quality Investing Score
3.5
Value Investing Score
6
Quarters > 0 > quarter
2025-06-30
Quarters > 0 > income Statement > revenue
6145000
Quarters > 0 > income Statement > cost Of Revenue
4224000
Quarters > 0 > income Statement > gross Profit
1921000
Quarters > 0 > income Statement > operating Expenses
1860000
Quarters > 0 > income Statement > operating Income
61000
Quarters > 0 > income Statement > interest Expense
40000
Quarters > 0 > income Statement > pretax Income
21000
Quarters > 0 > income Statement > net Income
21000
Quarters > 0 > income Statement > eps
0.000022483097528465208
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
934035000
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
373000
Quarters > 0 > income Statement > operating Margin
0.9926769731489016
Quarters > 0 > income Statement > total Other Income Expense Net
-40000
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
-461000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
2602000
Quarters > 0 > balance Sheet > inventories
2600000
Quarters > 0 > balance Sheet > total Current Assets
4741000
Quarters > 0 > balance Sheet > property Plant Equipment
1287000
Quarters > 0 > balance Sheet > total Assets
11500000
Quarters > 0 > balance Sheet > payables
1151000
Quarters > 0 > balance Sheet > short Term Debt
473000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
2938000
Quarters > 0 > balance Sheet > equity
8562000
Quarters > 0 > balance Sheet > currency_symbol
-
Quarters > 0 > cash Flow > net Income
21000
Quarters > 0 > cash Flow > depreciation
312000
Quarters > 0 > cash Flow > change In Working Capital
-515000
Quarters > 0 > cash Flow > cash From Operations
-239000
Quarters > 0 > cash Flow > capital Expenditures
25000
Quarters > 0 > cash Flow > cash From Investing
-120000
Quarters > 0 > cash Flow > cash From Financing
-310000
Quarters > 0 > cash Flow > net Change In Cash
-656000
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
0.000022483097528465208
Quarters > 0 > ratios > PB
43.85448142957254
Quarters > 0 > ratios > ROE
0.2452697967764541
Quarters > 0 > ratios > ROA
0.1826086956521739
Quarters > 0 > ratios > FCF
-264000
Quarters > 0 > ratios > Piotroski FScore
2
Quarters > 0 > ratios > fcf Percent
-0.042961757526444266
Quarters > 0 > health Score
42
Quarters > 1 > quarter
2024-12-31
Quarters > 1 > income Statement > revenue
5770000
Quarters > 1 > income Statement > cost Of Revenue
4368000
Quarters > 1 > income Statement > gross Profit
1402000
Quarters > 1 > income Statement > operating Expenses
1912000
Quarters > 1 > income Statement > operating Income
-510000
Quarters > 1 > income Statement > interest Expense
44000
Quarters > 1 > income Statement > pretax Income
-1563000
Quarters > 1 > income Statement > net Income
-1456000
Quarters > 1 > income Statement > eps
-0.0015608648690919947
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
932816177
Quarters > 1 > income Statement > income Tax Expense
-107000
Quarters > 1 > income Statement > EBITDA
-1144000
Quarters > 1 > income Statement > operating Margin
-8.838821490467938
Quarters > 1 > income Statement > total Other Income Expense Net
-1053000
Quarters > 1 > income Statement > currency_symbol
-
Quarters > 1 > balance Sheet > cash
195000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
1870000
Quarters > 1 > balance Sheet > inventories
2969000
Quarters > 1 > balance Sheet > total Current Assets
5320000
Quarters > 1 > balance Sheet > property Plant Equipment
1495000
Quarters > 1 > balance Sheet > total Assets
12238000
Quarters > 1 > balance Sheet > payables
1137000
Quarters > 1 > balance Sheet > short Term Debt
543000
Quarters > 1 > balance Sheet > long Term Debt
150000
Quarters > 1 > balance Sheet > total Liabilities
3697000
Quarters > 1 > balance Sheet > equity
8541000
Quarters > 1 > balance Sheet > currency_symbol
GBP
Quarters > 1 > cash Flow > net Income
-1456000
Quarters > 1 > cash Flow > depreciation
375000
Quarters > 1 > cash Flow > change In Working Capital
384000
Quarters > 1 > cash Flow > cash From Operations
453000
Quarters > 1 > cash Flow > capital Expenditures
30000
Quarters > 1 > cash Flow > cash From Investing
-139000
Quarters > 1 > cash Flow > cash From Financing
-340000
Quarters > 1 > cash Flow > net Change In Cash
-37000
Quarters > 1 > cash Flow > currency_symbol
-
Quarters > 1 > ratios > PE
-0.0015608648690919947
Quarters > 1 > ratios > PB
43.90494124271163
Quarters > 1 > ratios > ROE
-17.04718417047184
Quarters > 1 > ratios > ROA
-11.897368851119463
Quarters > 1 > ratios > FCF
423000
Quarters > 1 > ratios > Piotroski FScore
2
Quarters > 1 > ratios > fcf Percent
0.0733102253032929
Quarters > 1 > health Score
33
Quarters > 2 > quarter
2024-06-30
Quarters > 2 > income Statement > revenue
6175000
Quarters > 2 > income Statement > cost Of Revenue
4141000
Quarters > 2 > income Statement > gross Profit
2034000
Quarters > 2 > income Statement > operating Expenses
2162000
Quarters > 2 > income Statement > operating Income
-128000
Quarters > 2 > income Statement > interest Expense
55000
Quarters > 2 > income Statement > pretax Income
-487000
Quarters > 2 > income Statement > net Income
-487000
Quarters > 2 > income Statement > eps
-0.0005220750930515772
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
932816000
Quarters > 2 > income Statement > income Tax Expense
-304000
Quarters > 2 > income Statement > EBITDA
-115000
Quarters > 2 > income Statement > operating Margin
-2.0728744939271255
Quarters > 2 > income Statement > total Other Income Expense Net
-359000
Quarters > 2 > income Statement > currency_symbol
-
Quarters > 2 > balance Sheet > cash
232000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
2443000
Quarters > 2 > balance Sheet > inventories
3300000
Quarters > 2 > balance Sheet > total Current Assets
5975000
Quarters > 2 > balance Sheet > property Plant Equipment
1506000
Quarters > 2 > balance Sheet > total Assets
14086000
Quarters > 2 > balance Sheet > payables
1458000
Quarters > 2 > balance Sheet > short Term Debt
555000
Quarters > 2 > balance Sheet > long Term Debt
356000
Quarters > 2 > balance Sheet > total Liabilities
4089000
Quarters > 2 > balance Sheet > equity
9997000
Quarters > 2 > balance Sheet > currency_symbol
GBP
Quarters > 2 > cash Flow > net Income
-487000
Quarters > 2 > cash Flow > depreciation
317000
Quarters > 2 > cash Flow > change In Working Capital
-349000
Quarters > 2 > cash Flow > cash From Operations
-527000
Quarters > 2 > cash Flow > capital Expenditures
37000
Quarters > 2 > cash Flow > cash From Investing
-196000
Quarters > 2 > cash Flow > cash From Financing
-286000
Quarters > 2 > cash Flow > net Change In Cash
-980000
Quarters > 2 > cash Flow > currency_symbol
-
Quarters > 2 > ratios > PE
-0.0005220750930515772
Quarters > 2 > ratios > PB
37.51045633690107
Quarters > 2 > ratios > ROE
-4.871461438431529
Quarters > 2 > ratios > ROA
-3.4573335226465995
Quarters > 2 > ratios > FCF
-564000
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-0.09133603238866397
Quarters > 2 > health Score
26
Quarters > 3 > quarter
2023-12-31
Quarters > 3 > income Statement > revenue
6364000
Quarters > 3 > income Statement > cost Of Revenue
4919000
Quarters > 3 > income Statement > gross Profit
1445000
Quarters > 3 > income Statement > operating Expenses
1735000
Quarters > 3 > income Statement > operating Income
-290000
Quarters > 3 > income Statement > interest Expense
64000
Quarters > 3 > income Statement > pretax Income
-354000
Quarters > 3 > income Statement > net Income
-135000
Quarters > 3 > income Statement > eps
-0.00014472304761498577
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
932816177
Quarters > 3 > income Statement > income Tax Expense
-219000
Quarters > 3 > income Statement > EBITDA
96000
Quarters > 3 > income Statement > operating Margin
-4.556882463859209
Quarters > 3 > income Statement > total Other Income Expense Net
-64000
Quarters > 3 > income Statement > currency_symbol
-
Quarters > 3 > balance Sheet > cash
1212000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
1594000
Quarters > 3 > balance Sheet > inventories
2854000
Quarters > 3 > balance Sheet > total Current Assets
6089000
Quarters > 3 > balance Sheet > property Plant Equipment
1702000
Quarters > 3 > balance Sheet > total Assets
14320000
Quarters > 3 > balance Sheet > payables
1169000
Quarters > 3 > balance Sheet > short Term Debt
611000
Quarters > 3 > balance Sheet > long Term Debt
502000
Quarters > 3 > balance Sheet > total Liabilities
3836000
Quarters > 3 > balance Sheet > equity
10484000
Quarters > 3 > balance Sheet > currency_symbol
GBP
Quarters > 3 > cash Flow > net Income
-135000
Quarters > 3 > cash Flow > depreciation
386000
Quarters > 3 > cash Flow > change In Working Capital
237000
Quarters > 3 > cash Flow > cash From Operations
512000
Quarters > 3 > cash Flow > capital Expenditures
383000
Quarters > 3 > cash Flow > cash From Investing
-383000
Quarters > 3 > cash Flow > cash From Financing
-334000
Quarters > 3 > cash Flow > net Change In Cash
-200000
Quarters > 3 > cash Flow > currency_symbol
GBP
Quarters > 3 > ratios > PE
-0.00014472304761498577
Quarters > 3 > ratios > PB
35.768037309614655
Quarters > 3 > ratios > ROE
-1.287676459366654
Quarters > 3 > ratios > ROA
-0.9427374301675978
Quarters > 3 > ratios > FCF
129000
Quarters > 3 > ratios > Piotroski FScore
2
Quarters > 3 > ratios > fcf Percent
0.02027027027027027
Quarters > 3 > health Score
28
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
11945000
Annuals > 0 > income Statement > cost Of Revenue
8509000
Annuals > 0 > income Statement > gross Profit
3436000
Annuals > 0 > income Statement > operating Expenses
4227000
Annuals > 0 > income Statement > operating Income
-791000
Annuals > 0 > income Statement > interest Expense
99000
Annuals > 0 > income Statement > pretax Income
-2050000
Annuals > 0 > income Statement > net Income
-1943000
Annuals > 0 > income Statement > eps
-0.002082939863080869
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
932816177
Annuals > 0 > income Statement > income Tax Expense
-107000
Annuals > 0 > income Statement > EBITDA
-99000
Annuals > 0 > income Statement > operating Margin
-6.622017580577648
Annuals > 0 > income Statement > total Other Income Expense Net
-1259000
Annuals > 0 > income Statement > currency_symbol
GBP
Annuals > 0 > balance Sheet > cash
195000
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
1870000
Annuals > 0 > balance Sheet > inventories
2969000
Annuals > 0 > balance Sheet > total Current Assets
5320000
Annuals > 0 > balance Sheet > property Plant Equipment
1495000
Annuals > 0 > balance Sheet > total Assets
12238000
Annuals > 0 > balance Sheet > payables
1137000
Annuals > 0 > balance Sheet > short Term Debt
543000
Annuals > 0 > balance Sheet > long Term Debt
150000
Annuals > 0 > balance Sheet > total Liabilities
3697000
Annuals > 0 > balance Sheet > equity
8541000
Annuals > 0 > balance Sheet > currency_symbol
GBP
Annuals > 0 > cash Flow > net Income
-1943000
Annuals > 0 > cash Flow > depreciation
1852000
Annuals > 0 > cash Flow > change In Working Capital
35000
Annuals > 0 > cash Flow > cash From Operations
-74000
Annuals > 0 > cash Flow > capital Expenditures
335000
Annuals > 0 > cash Flow > cash From Investing
-335000
Annuals > 0 > cash Flow > cash From Financing
-626000
Annuals > 0 > cash Flow > net Change In Cash
-1017000
Annuals > 0 > cash Flow > currency_symbol
GBP
Annuals > 0 > ratios > PE
-0.002082939863080869
Annuals > 0 > ratios > PB
49.147322286617495
Annuals > 0 > ratios > ROE
-22.74909261210631
Annuals > 0 > ratios > ROA
-15.876777251184834
Annuals > 0 > ratios > FCF
-409000
Annuals > 0 > ratios > Piotroski FScore
1
Annuals > 0 > ratios > fcf Percent
-0.034240267894516535
Annuals > 0 > health Score
27
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
12014000
Annuals > 1 > income Statement > cost Of Revenue
8566000
Annuals > 1 > income Statement > gross Profit
3448000
Annuals > 1 > income Statement > operating Expenses
4044000
Annuals > 1 > income Statement > operating Income
-596000
Annuals > 1 > income Statement > interest Expense
132000
Annuals > 1 > income Statement > pretax Income
-728000
Annuals > 1 > income Statement > net Income
-509000
Annuals > 1 > income Statement > eps
-0.0005456594906372426
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
932816177
Annuals > 1 > income Statement > income Tax Expense
-219000
Annuals > 1 > income Statement > EBITDA
161000
Annuals > 1 > income Statement > operating Margin
-4.960878974529715
Annuals > 1 > income Statement > total Other Income Expense Net
-132000
Annuals > 1 > income Statement > currency_symbol
GBP
Annuals > 1 > balance Sheet > cash
1212000
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
1594000
Annuals > 1 > balance Sheet > inventories
2854000
Annuals > 1 > balance Sheet > total Current Assets
6089000
Annuals > 1 > balance Sheet > property Plant Equipment
1702000
Annuals > 1 > balance Sheet > total Assets
14320000
Annuals > 1 > balance Sheet > payables
1169000
Annuals > 1 > balance Sheet > short Term Debt
611000
Annuals > 1 > balance Sheet > long Term Debt
502000
Annuals > 1 > balance Sheet > total Liabilities
3836000
Annuals > 1 > balance Sheet > equity
10484000
Annuals > 1 > balance Sheet > currency_symbol
GBP
Annuals > 1 > cash Flow > net Income
-509000
Annuals > 1 > cash Flow > depreciation
757000
Annuals > 1 > cash Flow > change In Working Capital
43000
Annuals > 1 > cash Flow > cash From Operations
400000
Annuals > 1 > cash Flow > capital Expenditures
688000
Annuals > 1 > cash Flow > cash From Investing
-688000
Annuals > 1 > cash Flow > cash From Financing
-672000
Annuals > 1 > cash Flow > net Change In Cash
-987000
Annuals > 1 > cash Flow > currency_symbol
GBP
Annuals > 1 > ratios > PE
-0.0005456594906372426
Annuals > 1 > ratios > PB
40.03884773464327
Annuals > 1 > ratios > ROE
-4.855017169019458
Annuals > 1 > ratios > ROA
-3.554469273743017
Annuals > 1 > ratios > FCF
-288000
Annuals > 1 > ratios > Piotroski FScore
2
Annuals > 1 > ratios > fcf Percent
-0.023972032628599968
Annuals > 1 > health Score
28
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
11340000
Annuals > 2 > income Statement > cost Of Revenue
7418000
Annuals > 2 > income Statement > gross Profit
3922000
Annuals > 2 > income Statement > operating Expenses
3881000
Annuals > 2 > income Statement > operating Income
41000
Annuals > 2 > income Statement > interest Expense
98000
Annuals > 2 > income Statement > pretax Income
-57000
Annuals > 2 > income Statement > net Income
264000
Annuals > 2 > income Statement > eps
0.0002820675723576484
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
935945943
Annuals > 2 > income Statement > income Tax Expense
-321000
Annuals > 2 > income Statement > EBITDA
628000
Annuals > 2 > income Statement > operating Margin
0.36155202821869487
Annuals > 2 > income Statement > total Other Income Expense Net
-98000
Annuals > 2 > income Statement > currency_symbol
GBP
Annuals > 2 > balance Sheet > cash
2199000
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
1774000
Annuals > 2 > balance Sheet > inventories
3162000
Annuals > 2 > balance Sheet > total Current Assets
7416000
Annuals > 2 > balance Sheet > property Plant Equipment
1776000
Annuals > 2 > balance Sheet > total Assets
15595000
Annuals > 2 > balance Sheet > payables
1420000
Annuals > 2 > balance Sheet > short Term Debt
614000
Annuals > 2 > balance Sheet > long Term Debt
825000
Annuals > 2 > balance Sheet > total Liabilities
4632000
Annuals > 2 > balance Sheet > equity
10963000
Annuals > 2 > balance Sheet > currency_symbol
GBP
Annuals > 2 > cash Flow > net Income
264000
Annuals > 2 > cash Flow > depreciation
587000
Annuals > 2 > cash Flow > change In Working Capital
-353000
Annuals > 2 > cash Flow > cash From Operations
486000
Annuals > 2 > cash Flow > capital Expenditures
1078000
Annuals > 2 > cash Flow > cash From Investing
-1078000
Annuals > 2 > cash Flow > cash From Financing
-935000
Annuals > 2 > cash Flow > net Change In Cash
-1445000
Annuals > 2 > cash Flow > currency_symbol
GBP
Annuals > 2 > ratios > PE
0.0002820675723576484
Annuals > 2 > ratios > PB
38.41792158624464
Annuals > 2 > ratios > ROE
2.4080999726352275
Annuals > 2 > ratios > ROA
1.6928502725232446
Annuals > 2 > ratios > FCF
-592000
Annuals > 2 > ratios > Piotroski FScore
4
Annuals > 2 > ratios > fcf Percent
-0.052204585537918874
Annuals > 2 > health Score
47
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
9126000
Annuals > 3 > income Statement > cost Of Revenue
5995000
Annuals > 3 > income Statement > gross Profit
3131000
Annuals > 3 > income Statement > operating Expenses
3611000
Annuals > 3 > income Statement > operating Income
-480000
Annuals > 3 > income Statement > interest Expense
130000
Annuals > 3 > income Statement > pretax Income
-585000
Annuals > 3 > income Statement > net Income
-456000
Annuals > 3 > income Statement > eps
-0.0004868860436658922
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
936564122
Annuals > 3 > income Statement > income Tax Expense
-129000
Annuals > 3 > income Statement > EBITDA
247000
Annuals > 3 > income Statement > operating Margin
-5.259697567389876
Annuals > 3 > income Statement > total Other Income Expense Net
-130000
Annuals > 3 > income Statement > currency_symbol
GBP
Annuals > 3 > balance Sheet > cash
3644000
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
1408000
Annuals > 3 > balance Sheet > inventories
2965000
Annuals > 3 > balance Sheet > total Current Assets
8304000
Annuals > 3 > balance Sheet > property Plant Equipment
1198000
Annuals > 3 > balance Sheet > total Assets
15718000
Annuals > 3 > balance Sheet > payables
1090000
Annuals > 3 > balance Sheet > short Term Debt
2037000
Annuals > 3 > balance Sheet > long Term Debt
0
Annuals > 3 > balance Sheet > total Liabilities
5054000
Annuals > 3 > balance Sheet > equity
10664000
Annuals > 3 > balance Sheet > currency_symbol
GBP
Annuals > 3 > cash Flow > net Income
-456000
Annuals > 3 > cash Flow > depreciation
847000
Annuals > 3 > cash Flow > change In Working Capital
-938000
Annuals > 3 > cash Flow > cash From Operations
-433000
Annuals > 3 > cash Flow > capital Expenditures
657000
Annuals > 3 > cash Flow > cash From Investing
-657000
Annuals > 3 > cash Flow > cash From Financing
-532000
Annuals > 3 > cash Flow > net Change In Cash
-1634000
Annuals > 3 > cash Flow > currency_symbol
GBP
Annuals > 3 > ratios > PE
-0.0004868860436658922
Annuals > 3 > ratios > PB
39.52117919167292
Annuals > 3 > ratios > ROE
-4.276069017254313
Annuals > 3 > ratios > ROA
-2.901132459600458
Annuals > 3 > ratios > FCF
-1090000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-0.11943896559281175
Annuals > 3 > health Score
26
Valuation > metrics > PE
0.000022483097528465208
Valuation > metrics > PB
43.85448142957254
Valuation > final Score
40
Valuation > verdict
630.9% Overvalued
Profitability > metrics > ROE
0.2452697967764541
Profitability > metrics > ROA
0.44294452647120863
Profitability > metrics > Net Margin
0.003417412530512612
Profitability > final Score
2
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.34314412520439147
Risk > metrics > Interest Coverage
1.525
Risk > final Score
66
Risk > verdict
High
Liquidity > metrics > Current Ratio
2.919334975369458
Liquidity > metrics > Quick Ratio
1.3183497536945812
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
20
Prev Valuations > 1
20
Prev Valuations > 2
20
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
14
Prev Risks > 1
51
Prev Risks > 2
42
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T23:04:18.469Z
Earnings History > 0 > period
2026-03-31
Earnings History > 0 > report Date
2026-05-28
Earnings History > 0 > date
2026-03-31
Earnings History > 0 > before After Market
BeforeMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Surgical Innovations Group plc, together with its subsidiaries, engages in the design, manufacture, and export of medical products for use in laparoscopic and robotic minimally invasive surgery in the United Kingdom, Europe, the Asia Pacific, the United States, and internationally. The company operates through three segments: SI Brand, Original Equipment Manufacturer (OEM), and Distribution. It offers YelloPort Elite port access systems; YelloPort + Resposable port access systems; LogiCut, a disposable laparoscopic scissors; Logic, a reusable laparoscopic grasping forceps and dissectors; LogiFlex, a dual purpose, Resposable device for blunt dissection and gastric band retrieval; FastClamp, a reusable laparoscopic clamping system, designed to fixate a range of instrumentation in position during minimally invasive surgery; PretzelFlex, a pretzel shaped organ and tissue retractor, designed for use in minimally invasive surgery; and LogiTube, a calibration tubing for gastric pouch sizing during sleeve gastrectomy, mini gastric bypass/one-anastomosis gastric bypass, or revision surgery for these procedures. The company also researches, develops, manufactures, and distributes minimally invasive devices for third party medical device companies through either own label or co-branding; minimally invasive technology products for precision engineering applications; and services for design and building of instruments. In addition, it distributes specialist medical products; and designs and manufactures autologous blood products. The company sells its products through independent healthcare distributors, as well as its own label products through OEM relationships. The company was incorporated in 1988 and is headquartered in Leeds, the United Kingdom.
Stock Price
GBp 0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AShowing 2 of 10
(Last Updated 2025-06-30)
Rating:
BUY
$
Analyst Picks
Strong Buy
0
Buy
1
Hold
0
Sell
0
Strong Sell
0
(Last Updated 2025-06-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Surgical Innovations Group plc
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2026-03-31
EPS Estimate
—
Date
—
EPS Actual
—
EPS Estimate
—
EPS Difference
—
Surprise Percent
undefined%
(Last Updated 2025-06-30)
(Last Updated 2025-06-30)
Revenue
£ 0
Cost Of Revenue
£ 0
Gross Profit
£ 0
Operating Expenses
£ 0
Operating Income
£ 0
Interest Expense
£ 0
Pretax Income
£ 0
Net Income
£ 0
Income Tax Expense
£ 0
EBITDA
£ 0
Total Other Income Expense Net
£ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-06-30)
Cash
£ 0
Short Term Investments
£ 0
Receivables
£ 0
Inventories
£ 0
Total Current Assets
£ 0
Property Plant Equipment
£ 0
Total Assets
£ 0
Payables
£ 0
Short Term Debt
£ 0
Long Term Debt
£ 0
Total Liabilities
£ 0
Equity
£ 0
(Last Updated 2025-06-30)
Net Income
£ 0
Depreciation
£ 0
Change In Working Capital
£ 0
Cash From Operations
£ 0
Capital Expenditures
£ 0
Cash From Investing
£ 0
Cash From Financing
£ 0
Net Change In Cash
£ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.